Revumenib

revumenib · Syndax Pharmaceuticals

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Revumenib, covering 2024-08-13 to 2026-07-06. Get the full timeline:

Most recent: Clinical Trial Results: Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors [Phase 1, Phase 2]